Comparison of Abbott ID Now, DiaSorin Simplexa, and CDC FDA Emergency Use Authorization Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Individuals Diagnosed with COVID-19.
Daniel D RhoadsSree S CherianKatharine RomanLisa M StempakChristine L SchmotzerNavid SadriPublished in: Journal of clinical microbiology (2020)